Genome Biology

Go back or start search again

General information ?

  • Published by: BioMed Central
  • ISSN: 1474-760X
  • Last checked date: 03/2020
  • Scope: Genome Biology covers all areas of biology and biomedicine studied from a genomic and post-genomic perspective. Content includes research, new methods and software tools, and reviews, opinions and commentaries. Areas covered include, but are not limited to: sequence analysis; bioinformatics; insights into molecular, cellular and organismal biology; functional genomics; epigenomics; population genomics; proteomics; comparative biology and evolution; systems and network biology; genome editing and engineering; genomics of disease; and clinical genomics
  • Additional free text: Co-submissions to other BMC ‘flagship’ journals. If a paper is potentially appropriate in scope for Genome Biology and either Genome Medicine or BMC Biology, authors have the opportunity to submit a manuscript for joint consideration at two of these journals at the same time. For a paper to be considered as a co-submission, the authors should upload their manuscript to one of the two journals and note in their cover letter that they would like a co-consideration with the second journal. Each journal will evaluate the paper independently. If both journals decide to send the paper for review, the editors will select reviewers together for a peer review process that evaluates the manuscript for both journals, and will make independent decisions based on reviewers’ feedback.
  • Website
  • Instructions for authors


  • Main subject area: Biology
  • Breadth of subject area: Top level subject
  • Peer review?

  • Peer review type: Conventional
  • Peer review openness: Reports published anon
  • Selectivity: Selective (IF ~8-15)
  • Open access?

  • Free to read option: Paper can be free for anyone to read
  • Allows green OA: Not applicable as gold
  • Has waivers: Yes
  • Has membership system: Institutional membership
  • Access type: Full gold
  • Licence: All papers are CC BY
  • Level of APC: Over $4500
  • Speed?

  • Speed to first decision: Unknown
  • Speed from acceptance to publication: Unknown
  • Other?

  • Ownership of publisher: Company
  • Length restrictions: None
  • Provides altmetrics: Altmetric
  • CrossMark implemented: Yes
  • Has a 2015 impact factor: Yes
  • Copyedits: Yes